Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 530
Healthy volunteers: no

Brief summary:
This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.

Detailed description:

Arms:
arm 1: sitagliptin 100 mg arm 2: placebo

Interventions: intervention 1: sitagliptin phosphate intervention 2: Comparator: placebo
Intervention descriptions: intervention 1: Sitagliptin 100 mg administered as one oral tablet once daily before the morning meal for up to 18 weeks. intervention 2: placebo to match Sitagliptin 100 mg administered as one oral tablet once daily before the morning meal for up to 18 weeks

Protocol document: